Abstracts Archive - Page 304 of 1683 - ATC Abstracts

2021 American Transplant Congress
High Levels of Sars-cov-2 Detected in Immunosuppressed Covid-19 Patient Environments Weeks Following Initial Positive Test
C. E. Kuschner¹, Z. Brune², L. B. Becker¹, L. Teperman¹
¹North Shore University Hospital, Manhasset, NY, ²Feinstein Institutes for Medical Research, Manhasset, NY
*Purpose: COVID-19 is a novel viral illness associated with significantly worse mortality, prolonged disease course, and extended periods of viral shedding in transplant patients on…
2021 American Transplant Congress
SARS-CoV-2 Infection in Solid Organ Transplant Recipients: A Retrospective Cohort Study
A. Adeel
Infectious Diseases, University of Massachusetts, Worcester, MA
*Purpose: Initial studies of COVID-19 in solid organ transplant (SOT) recipients demonstrated high mortality rates, but more recent comparative data shows contradictory results.*Methods: We evaluated…
2021 American Transplant Congress
Systemic Venous versus Portal Venous Drainage in Simultaneous Pancreas-kidney Transplantation: A Matched-pair Analysis
B. Sharda
Wake Forest Baptist Medical Center, Winston Salem, NC
*Purpose: Portal venous drainage of pancreatic transplant appears more physiologic compared to systemic venous drainage. However, present data does not support the superiority of one…
2021 American Transplant Congress
Outcomes of Simultaneous Kidney-Pancreas Transplantation in Patients with Type-I and Type-II Diabetes Mellitus
H. Shokouh-Amiri¹, M. S. Naseer¹, A. Palermini¹, D. Aultman¹, R. McMillan¹, S. Tandukar², N. Singh², G. Zibari¹
¹Advanced Surgery, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, ²Transplant Nephrology, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA
*Purpose: UNOS approved simultaneous kidney-pancreas transplantation (SKPT) for type-II diabetes mellitus (DM) in Oct 2014. There is limited data comparing outcomes of SKPT in type-I…
2021 American Transplant Congress
COVID-19 Transmission within One Year from Pancreas and Kidney Recipients
H. Sarumi, J. Fisher, B. Johnson, T. Pruett
University of Minnesota, Minneapolis, MN
*Purpose: The current pandemic has created uncertainty surrounding the transmission of COVID-19. It was recently published that in the general population, household contacts have a…
2021 American Transplant Congress
Systematic Evaluation of Immunosuppressant Drug Tolerability in Lung Transplant Recipients with Short Telomere Syndrome
R. Patolia¹, R. Guzy², L. Potter¹
¹Department of Pharmacy, University of Chicago Medicine, Chicago, IL, ²Department of Medicine, Division of Pulmonology, University of Chicago Medicine, Chicago, IL
*Purpose: Lung transplant recipients with short telomere syndrome are at high risk of hematologic complications. Consequently, patients with short telomere syndrome may require more frequent…
2021 American Transplant Congress
Impact of Electronic Donor Referral Technology on Deceased Donor Referrals
B. Boyarsky¹, J. R. DiRito², K. Vanterpool¹, J. Piano³, W. Liu³, J. Hewlett⁴, C. Trahan⁴, D. Segev¹, M. Levan¹, A. Massie¹, P. Niles⁴
¹Johns Hopkins, Baltimore, MD, ²Yale, New Haven, CT, ³Transplant Connect, Santa Monica, CA, ⁴Southwest Transplant Alliance, Dallas, TX
*Purpose: Hospitals likely fail to refer many medically eligible potential deceased donors to OPOs. As such, increasing eligible referrals may increase the donor pool. We…
2021 American Transplant Congress
Living Organ Donor Perspectives on Covid-19 Vaccines
M. N. Harhay¹, A. Klassen², H. Zaidi¹, M. Mittelman³, R. Bertha³, R. Mannon⁴, K. Lentine⁵
¹Medicine, Drexel University, Philadelphia, PA, ²Drexel University, Philadelphia, PA, ³American Living Organ Donor Fund, Philadelphia, PA, ⁴University of Nebraska Medical Center, Omaha, NE, ⁵Saint Louis University, Saint Louis, MO
*Purpose: Promoting widespread COVID-19 vaccinations is a crucial strategy to protect living organ donors and transplant recipients during the pandemic. We examined perspectives and sources…
2021 American Transplant Congress
Characterization of SGLT2 Inhibitor Use After Abdominal Transplant
F. Hailemariam¹, S. Yeager², J. Schulte³, P. Singh¹, A. Yadav¹
¹Transplant Nephrology, Thomas Jefferson University Hospital, Philadelphia, PA, ²Abdominal Transplant Pharmacist, Thomas Jefferson University Hospital, Philadelphia, PA, ³Abdominal Transplant, Clinical Pharmacist, Thomas Jefferson University Hospital, Philadelphia, PA
*Purpose: Post solid organ transplantation, diabetic kidney disease (DKD) can progress due to recurrent pre-transplantation diabetes or the development of post-transplantation diabetes mellitus (PTDM). This…
2021 American Transplant Congress
Letermovir Prophylaxis in Solid Organ Transplant – CMV Breakthrough and Tacrolimus Drug Interaction
R. Winstead¹, D. Kumar¹, A. Brown¹, I. Yakubu¹, C. Song¹, L. Thacker², G. Gupta¹
¹Virginia Commonwealth University Health, Richmond, VA, ²Virginia Commonwealth University, Richmond, VA
*Purpose: Valganciclovir is the preferred drug for cytomegalovirus (CMV) prophylaxis in solid organ transplantation. A limitation to its use is profound myelosuppression. Letermovir is a…